Drug intelligence / Profile preview

qishunbaolier

Development stage: Unknown
Administration: Oral

Overview

Qishunbaolier (QSBLE) is a traditional Mongolian medicine used primarily for its immune-modulating properties. It has demonstrated high curative effects, particularly in the treatment of immune thrombocytopenia, with reports indicating reduced relapse rates and minimal side effects. The precise mechanism of action is not fully elucidated but appears to involve modulation of immune function and regulation of miRNA expression in patients with immune-related disorders[1][7]. Qishunbaolier is typically formulated as a multi-component herbal preparation according to Mongolian medical principles.

Other names: QSBLE

Beyond the preview

Go deeper on qishunbaolier.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on qishunbaolier.

Explore the full profile